FCGR3A and COVID-19: Otherwise, Qin, S. et al. observed that, in critical patients with COVID-19, the absolute number of total monocytes and CD16− monocytes was significantly decreased but CD16+ pro-inflammatory monocytes were increased compared to healthy controls [34].